This year, at the Annual Fordham IP Law & Policy Conference, we heard Lord Justice Birss reflect on how we are living through a transformative era in intellectual property (IP) law. In the age of…
Tempus fugit. It’s hard to believe that the UPC opened for business over two years ago and, after a relatively slow start, is now flourishing. It would be fair to say that, with certain notable…
As is well known in the life sciences community in Europe, both the Commission and the Parliament have proposed reforms to the Medicines Directive which, if implemented, would serve to broaden the…
On 9 January 2025 I reported on Parts 1 and 2 of a three-part article in EPI Information by Tamaris Bucher, a Principal Patent Attorney at Novartis Pharma AG, on the current approach to antibody…
The festive period normally leads to a slight slow-down in work in Europe and as such, it can provide the opportunity to catch up on wider reading as well as to grab a little rest. In between the…
Many thanks to all of the entrants to the UPC Christmas quiz – a number of the entries scored 100%.
Of all of these top scoring entries, we have selected one winner at random….. Alexander Jamnišek. …
As we approach 18 months since the UPC opened its doors and the festive season, we thought this would be a good time to offer our readers the chance to showcase their UPC knowledge by participating…
A recent decision from Joanna Smith J dealing with the costs of a withdrawn application in a case before the English Patents Court contains an important postscript and suggests that the rules in the…
On 17 April 2024, the Court of Appeal of the UPC handed down its decision concerning the language of proceedings in the (undoubtedly ground-breaking) case of Curio Bioscience v 10x Genomics. Curio…
